Meridian Medica — Pleurisy Root

01

Identity

Botanical Profile

Asclepias tuberosa L. — Root (dried; no fresh root internally). Native to eastern and central North America, from Ontario and the Atlantic coast west to Colorado and south to Florida and Texas. One of the most beautiful native wildflowers of the eastern United States and Great Plains. Common in dry prairies, open woodlands, roadsides, and rocky slopes.

Dried root: mildly bitter, slightly acrid, faintly aromatic. Dried root is pale gray-brown; fibrous, with longitudinal ridges. Taste is bitter with a mild astringency. IMPORTANT: Fresh root contains cardiac glycoside-related compounds and latex that cause significant GI irritation — always use dried root only for internal preparations. The fresh plant's milky latex (like all Asclepias species) is a mucus membrane irritant.

Species Integrity

Asclepias tuberosa is the primary medicinal species and is distinct from other Asclepias species. A. syriaca (Common Milkweed) and A. incarnata (Swamp Milkweed) are edible and used medicinally but have different therapeutic profiles.

02

Compounds

Active Compound Profile

Cardenolides (cardenolide glycosides, related to cardiac glycosides)

Trace to 0.3% in dried root (much lower than A. syriaca)

Mild positive inotropic (at low doses); diuretic; expectorant action; pro-secretory at respiratory mucosa

Flavonoids (quercetin, kaempferol, rutin derivatives, isorhamnetin)

1–3% in aerial parts and root

Anti-inflammatory; antioxidant; antihistamine; mild bronchodilatory (quercetin stabilizes mast cells); capillary protection

Terpenoids (ursolic acid, oleanolic acid, beta-sitosterol)

0.5–2.0%

Anti-inflammatory (COX and 5-LOX inhibition); immunomodulatory; hepatoprotective

Resins and bitter principles

2–5%

Diaphoretic; expectorant; cathartic at high doses; mucolytic at therapeutic doses

Absorption

Decoction of dried root: Flavonoids, terpenoids, and water-soluble bitter principles extract efficiently in hot water; primary traditional and therapeutic preparation

03

Pathways

Mechanism of Action

★★★☆☆ Diaphoretic / Diaphoretic-Expectorant Synergy Root constituents promote perspiration and simultaneously increase mucosal secretion in the respiratory tract (diaphoretic-expectorant synergy); this combination is uniquely suited to respiratory infections with both systemic fever and pulmonary congestion

★★★☆☆ Serous Membrane Anti-Exudative Eclectic physicians described pleurisy root as reducing exudation from serous membranes (pleura, pericardium) — likely through diuretic reduction of systemic fluid, anti-inflammatory COX/LOX inhibition, and improved lymphatic clearance of pleural space

★★★☆☆ Anti-Inflammatory (Flavonoid / Terpenoid) Quercetin mast cell stabilization, kaempferol COX-2 inhibition, and ursolic acid 5-LOX inhibition collectively reduce allergic and inflammatory mediator release in respiratory tissue

★★★☆☆ Bronchodilatory / Antispasmodic Quercetin and flavonoid bronchodilatory activity (phosphodiesterase inhibition, beta-2 receptor potentiation) combined with mild smooth muscle relaxation of bronchioles

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
hs-CRP	↓ Decrease	<1.0 mg/L	Flavonoid and terpenoid anti-inflammatory activity reduces systemic inflammatory markers
IgE (total serum)	↓ Decrease	<100 IU/mL	Quercetin mast cell stabilization reduces IgE-mediated allergic response and total IgE production
FEV1/FVC (spirometry)	↑ Improve	>0.7 ratio (normal)	Bronchodilatory and anti-inflammatory action improves airway function in reactive airway disease

05

Extraction

Extraction & Preparation

Dried root decoction (20 min simmer): Good for flavonoids, bitter principles, cardenolides; moderate for terpenoids

Solubility · Water-soluble; also ethanol-solubleMenstruum · 60% ethanol — DRIED root onlyPlant material · DRIED root only (Asclepias tuberosa)Maceration time · 4 weeks (agitate daily)Ratio · 1:5 dried

07

Dosing

Dosing Framework

Take with meals to reduce potential GI irritation from cardenolide content.

Dose 1

Conservative start: 1 mL tincture or 1/2 cup decoction, 2x daily

Always start conservative with this herb; observe for any nausea, cardiac symptoms, or excessive sweating

Dose 2

Therapeutic: 1–2 mL tincture or 1 cup decoction, 3x daily

Standard Eclectic dose range; short-course use for acute conditions (5–14 days)

Dose 3

Acute respiratory fever: warm decoction 3–4 cups in first 24 hours

Hot decoction in warm environment; combine with other diaphoretics

08

Synergies

Synergy Partners

★★★☆☆ Elecampane (Inula helenium) Complementary respiratory action; elecampane's inulin prebiotics + sesquiterpene antimicrobials + expectorant action complement pleurisy root's diaphoretic-expectorant + anti-exudative effects for comprehensive lower respiratory support

★★★☆☆ Mullein (Verbascum thapsus) Synergistic respiratory demulcent and expectorant; mullein's saponin-mediated mucosal secretion and soothing action complement pleurisy root's diaphoretic expectorant mechanism

★★★☆☆ Boneset (Eupatorium perfoliatum) Classic Eclectic combination; boneset's profound diaphoretic and anti-influenza activity complements pleurisy root's respiratory anti-exudative action; together they address 'flu with chest involvement'

★★★☆☆ Elderflower (Sambucus nigra) Complementary diaphoretic; elderflower's gentle diaphoresis combines with pleurisy root's stronger diaphoretic for layered fever management with upper and lower respiratory coverage

Signature Stack

THE RESPIRATORY DEFENSE TRIO
Components: Pleurisy Root (root) + Elecampane (root) + Mullein (leaf) · Multi-pathway convergence: Diaphoretic-expectorant serous membrane anti-exudative (pleurisy root) + deep lung antimicrobial inulin prebiotics (elecampane) + soothing mucosal demulcent expectorant (mullein) · This trio addresses the full spectrum of lower respiratory illness — from the systemic fever and serous membrane involvement (pleurisy root) to the deep lung antimicrobial and prebiotic action (elecampane) to the mucosal soothing and gentle expectorant (mullein). · Practical integration: Respiratory Restoration Decoction; acute respiratory illness protocol; specialized application for pleuritic chest involvement; available as Zone 9a home-grown preparation (A. tuberosa thrives in SE Texas).

09

Safety

Contraindications & Interactions

Minor Cardiac medications (absolute) Pleurisy root contains cardenolide compounds related to cardiac glycosides. Combining with digoxin, other cardiac glycosides, antiarrhythmics, or quinidine is potentially dangerous due to additive cardiac effects.

Avoid Pregnancy (absolute) AHPA Class 2b: uterotonic activity at higher doses. Native American traditional use for inducing labor. Contraindicated throughout pregnancy.

Minor Fresh root toxicity Fresh A. tuberosa root contains emetic compounds (related to the milky latex of other Asclepias species — though A. tuberosa has minimal latex, the fresh root still has emetic activity at higher doses). Drying neutralizes/reduces this risk.

Minor High dose cardiac effects At doses significantly above the recommended range, cardenolide content could produce cardiac effects (bradycardia, arrhythmia) — the narrow therapeutic window of cardiac glycoside-class compounds requires dose respect.

Minor GI sensitivity Resinous bitter compounds can cause nausea at higher doses or on an empty stomach, particularly in sensitive individuals.

11

Evidence

Evidence Base

★★★☆☆ Diaphoretic / Expectorant Moderate — Strong Eclectic tradition; consistent Native American use; mechanistic basis; limited modern trials

★★☆☆☆ Serous Membrane Anti-Exudative (Pleurisy) Preliminary — Strong Eclectic tradition; no modern pharmacological confirmation of serous membrane mechanism

★★★☆☆ Anti-Inflammatory (Flavonoid/Terpenoid) Moderate — Class evidence for quercetin/ursolic acid anti-inflammatory; A. tuberosa-specific data limited

★★★★★ Zone 9a Native Plant / Ecological Definitive — A. tuberosa is native to SE Texas and thrives in Zone 9a conditions

Evidence Gaps

Pleurisy root has received almost no modern pharmacological attention despite its strong Eclectic tradition and interesting cardenolide-flavonoid phytochemistry. A primary research need is basic phytochemical characterization of A. tuberosa cardenolide and flavonoid content, followed by in vitro studies of the proposed serous membrane anti-exudative mechanism. Clinical validation for the acute respiratory illness application would require a small pilot study comparing pleurisy root decoction to placebo in acute bronchitis or pleurisy.

Quality Alert

Pleurisy root (A. tuberosa) is sometimes substituted with other Asclepias species, particularly A. syriaca (Common Milkweed). The different species have different cardenolide profiles and safety considerations — species authentication is important.

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Respiratory Restoration Decoction (signature preparation)

1 cup, 3–4x daily during acute respiratory illness

Feed the Markers

Pleurisy Root appears in the following Meridian Medica protocol contexts: